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ABSTRACT
Introduction: Current prognostic markers have improved survival prediction, however, it has not 
advanced treatment strategies. Gene expression profiling may identify biological markers suitable as 
therapeutic targets. Leukaemia stem cell is associated with adverse outcome, however, its biological 
characteristics are still being investigated. We observed higher in vitro cell viability in acute myeloid 
leukaemia (AML) samples with poor prognosis, which may be stem cell related. Objective: The 
objective of this study was to profile highly expressed genes in an AML sample of poor prognosis/high 
viability and compare with a sample of good prognosis/low viability. Method: Subtractive hybridization 
was performed on two AML samples with high blast counts (>80%), a poor prognosis, PP (disease free 
survival, DFS<12 months) and a good prognosis, GP (DFS>12 months) sample. The PP sample had 
higher CD34+ counts (73% vs 46%) and higher cell viability than the GP sample. cDNA libraries were 
subsequently cloned and sequenced. Results: cDNA subtracted from the PP samples was identified 
as genes active during fetal/embryonic development (LCOR, CNOT1, ORMDL1), HOX- related genes 
(HOXA3, PBX3, SF3B1), hematopoiesis (SELL, IL-3RA) and aerobic glycolysis/hypoxia (PGK1, 
HIGD1A) -associated genes. Majority of GP clones isolated contained genes involved in oxidative 
phosphorylation, OXPHOS (COXs, ATPs, MTND4 and MTRNR2), protein synthesis (including 
ribosomal proteins, initiating and elongation factors), chromatin remodeling (H2AFZ, PTMA), cell 
motility (MALAT1, CALM2, TMSB4X), and mitochondria (HSPA9, MPO) genes. Conclusion: Thus, 
the PP sample exhibited stem cell-like features while the GP sample showed cells at a high level of cell 
activity. These genes are potential prognostic markers and targets for therapy.
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INTRODUCTION
Acute myeloid leukemia (AML) is a hematological malignancy characterized by 20% or more blasts in the peripheral 
blood or bone marrow. Median age of presentation is in the late 60s. Early death (death within 30 days from diagnosis) 
occurs in 19% of patients. Standard chemotherapy with anthracycline and arabinoside (‘3 plus 7’) achieves complete 
remission in 65% de novo AML. Median overall survival was 1119 days for patients aged 16-55 year old (N=554), 
350 days for those aged 56-65 year old (N=437) and 80 days for patients aged 76-89 year old (N=968) (1). Thus, 
survival rates in patients remain poor. Identifying patients with poor response to treatment is important in tailoring 
best therapy. Current prognostication utilize genomic markers such as cytogenetic abnormalities as well as gene 
mutations, however, accurate prediction remains unsatisfactory (2-4). Gene expression profiling may reveal patterns 
that reflect underlying biology of disease subtypes (3). 
AML is a heterogeneous disease, diverse in phenotype as well as genotype. Malignant transformation occur 
at early stages of hematopoietic development and differentiation which remains in WHO classification (5). Gene 
expression profiling has identified genes (4) and stem cell related genes (2) associated with poor prognosis in AML. 
There is limited literature on gene profiling of leukemia stem cells in AML. We observed cell viability of AML cells 
cultured for 3 days in vitro inversely correlated with disease free survival (6). High in vitro cell proliferation reflects 
self-renewal capacity associated with stem cells (7). Thus, AML of poor prognosis/high cell viability may be a source 
for leukaemia stem cells and provide an opportunity to dissect its biological properties. 
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The aim of this study was to identify differentially expressed genes in two AML samples from patients with 
different survival rates using subtractive hybridization. From the genetic profiles obtained it was shown that both 
samples exhibited distinct patterns in function and biology.
MATERIAL AND METHODS
Samples 
Excess bone marrow/peripheral blood samples from acute myeloid leukemia patients were obtained from Hematology 
Laboratory, Universiti Kebangsaan Malaysia Medical Centre. Samples were collected between September 1999 and 
December 2002. Approval was obtained from the Institution and the Medical Research Ethics Committee, Universiti 
Putra Malaysia. All procedures were in accordance with The Code of Ethics of the World Medical Association 
(Declaration of Helsinki). Treatment of AML patients were according to the Berlin-Frankfurt-Munich (BFM)-83 
protocol with modifications. Disease free survival (DFS) was determined from the time complete remission was 
diagnosed till time first relapse was diagnosed or till end of study. Diagnosis was made by Hematologists. Poor 
prognosis was defined by short DFS (<12 months) and good prognosis defined by longer DFS (>12 months).
Two samples were selected based on poor prognosis (PP-AML) and good prognosis (GP-AML). PP-AML 
was a peripheral blood sample from a 46 year-old male, newly diagnosed AML, M4 FAB (French-American-British 
classification). Peripheral blood of PP-AML consists of 95% blast of which 73% were CD34+. GP-AML was a bone 
marrow sample from a 7 year-old female, newly diagnosed AML, M2 FAB. Peripheral blood of GP-AML consists 
of >99% blast. Bone marrow of GP-AML contained 46% CD34+ blast (and 95% CD13). Both samples were taken 
before commencement of chemotherapy. Selection for the two AML samples was also based on extreme ends in in 
vitro cell viability determined in an earlier study(6); in vitro viability was high in poor prognosis (PP-AML) patient 
and low in good prognosis (GP-AML) patient. RNA from the peripheral blood of PP-AML and bone marrow of GP-
AML were isolated for subtractive hybridization analysis.
Cell isolation and RNA extraction
Mononuclear cells from bone marrow / peripheral blood aspirates were isolated by gradient density centrifugation 
on Ficoll-Hypaque (Amersham Pharmacia Biotech AB, Uppsala, Sweden). Cells were stored under liquid nitrogen 
condition until further analysis.
Total RNA was extracted using TRI reagent based protocol (Tri-Reagent, Life Technology, USA). Quality 
and quantity determined on Nanodrop 1000 spectrophotometer (Thermo Scientific, Wilmington, USA) while RNA 
integrity was verified by detection of the 28S and 18S bands after electrophoresis on ethidium bromide stained 
agarose gels. Lambda DNA/EcoR I + Hind III DNA Marker (Promega, Wisconsin, USA) was run together on the 
gel. The lambda DNA is completely digested with EcoR I and Hind III and yields 12 double stranded Lambda DNA 
fragments: 21226, 5148, 4973, 4268, 3530, 2027, 1904, 1584, 1375, 947, 831, 564 bp.
cDNA synthesis and amplification
First strand cDNA was synthesized from RNA (1 mg) with the Super SMART™ PCR cDNA Synthesis Kit 
(Clontech, BD Biosciences) using the SMART CDS primer and SMART 11A oligonucleotide and PowerScript 
reverse transcriptase according to manufacturer’s protocol. This was followed with column chromatography to purify 
resulting product. cDNA was then amplified by LD PCR with PCR Primer 11A and the Advantage 2 Polymerase 
Mix for amplification of long PCR templates, high yield and high fidelity (Advantage 2 PCR Kit, Clontech BD 
Biosciences). PCR was conducted in a thermal cycler (T-gradient Biometra, Montreal Biotech Inc., Kirkland, 
Canada) at thermal cycling profiles given in manufacturer’s guide. A further purification step was then conducted 
with phenol:chloroform:isoamyl alcohol and n-butanol. As only amplified ds cDNA larger than 500 bp was to be used 
for further experiment, the resultant PCR product was run on standard agarose (1%), gel containing correct product 
size excised and purified with the QIAquick Gel Extraction kit (Qiagen, USA) according to manufacturer’s manual. 
The Super SMART kit thus uses small amount of RNA and designed to enrich for full-length cDNA and ensure gene 
representation as well as amplify cDNA. 
Subtractive hybridization and cloning
Following cDNA synthesis and amplification, procedure continued with the PCR-Select cDNA Subtractive Kit, 
(Clontech BD Biosciences, USA). Rsa I digestion was carried out for 3 hours at 37oC on both tester (AML sample 
1) and driver (AML sample 2) to generate shorter, blunt-ended ds cDNA fragments. This was necessary to continue 
with adaptor ligation and subtraction. After this restriction enzyme digestion, the reaction was purified using Wizard 
SV Gel and PCR Cleanup System (Promega, USA) according to manufacturer’s protocol. Subsequently, DNA was 
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precipitated with 4M ammounium acetate and 95% ethanol, pellet washed with 80% ethanol and finally dissolved 
in 6.7 microliter TNE buffer. cDNA before and after enzyme digestion was checked on gel electrophoresis. At this 
point one of the AML sample was chosen as the tester while the other as driver cDNA for the subsequent experiment. 
Adapter ligation was performed on tester cDNA (since this procedure will only enrich for differentially expressed 
sequences present in poly A+ RNA of the tester sample, this experiment was also performed with the cDNA samples 
reversed). Two adapter ligations were performed on each tester cDNA. Two aliquots were made of each cDNA; one 
was added with Adapter 1 while the other with Adapter 2R. After ligation with T4 DNA ligase, an aliquot was taken 
from each tube and mixed in a third tube to be the Unsubtracted tester control to act as the positive control for ligation 
and later as negative control for ligation. Before continuing with subtraction, the ligation efficiency analysis was 
conducted on ligated samples using PCR amplification method with primers supplied with the kit. 
There are two steps in subtractive hybridization. In the first, excess driver cDNA was mixed with the two 
ligated tester cDNAs in separate tubes in hybridization buffer provided. The mixture was then heat denatured and 
allowed to anneal in a thermocycler (T-gradient Biometra, Montreal Biotech Inc., Kirkland, Canada) at 68oC for 8 
hr. Unhybridized ss cDNAs are the differentially expressed sequences enriched for the second hybridization step. In 
the second step, the two samples from first hybridization were mixed together and fresh denatured driver cDNA was 
added according to instructions in the manual. It is important not to denature products in the reactant tube at this point. 
Incubation was carried out at 68oC overnight. The second incubation causes new hybrid molecules to form between 
differentially expressed cDNAs labeled with different adapters. The final step involved two PCR amplification, a 
primary PCR followed by nested PCR was performed on subtracted and unsubtracted cDNA and a PCR control 
subtracted cDNA provided in the kit. After combining all necessary reagents as detailed in the manual, the reaction 
was first incubated at 75oC for 5 min to fill in missing strands of the adapters necessary as binding site for the PCR 
Primer 1 in the primary PCR. PCR Primer 1 binds the adapters. PCR amplification was carried out with the thermal 
cycling profile provided in the manual. Subsequently, 1 microliter from these reactions were used for nested PCR 
using nested primers provided in the kit. PCR reactions were amplified using the Advantage cDNA Polymerase Mix. 
Results were analyzed by gel electrophoresis. Thus, this kit selects for low-abundance mRNA as well as amplify and 
enrich for differentially expressed genes. 
Subtracted libraries were cloned into pGEM-T vectors using pGEM-T Easy Vector system (Promega, USA) and 
transformed by heat shock method into JM109 Competent Cells (Promega, USA). All procedures were performed 
according to manufacturers’ protocols. Recombinant strains were selected on LB-ampicillin (50 microgram/mL) agar 
plates spread with 50 microliter [1 of 5-bromo-4-chloro-3-indolyl-P-Dgalactopyranoside (40 mg/mL) (International 
Biotechnologies, Inc.) and eight microliter of 100 mM isopropyl-thiogalactoside (IPTG; Sigma Chemical Co., St. 
Louis, Mo.). White colonies were picked after 24 hours growth.
Colony polymerase chain reaction (PCR)
Colony PCR were performed to amplify inserts directly in E. coli colonies. Cell suspensions of selected 
colonies were heated at 94oC for 10 min, followed by PCR in 0.5 microMolar of each primer pair, 0.2mM 
dNTP, 1 U of Taq DNA polymerase. pGEM-T primers T7F (5′-TAATACGACTCACTATAGGG-3′) and SP6R 
(5′-GATTTAGGTGACACTATAG-3′) were used. PCR conditions were as follows: 5 min at 94oC for hot start, 
followed by 30 cycles of 94oC for 40 sec, 56oC for 40 sec for annealing, and 72oC for 3 min, with a final extension 
of 4 minute at 72oC . The amplified products were analyzed on 1% agarose gels and visualized by ethidium bromide 
staining.
Sequencing and Gene Identification
The amplified products were purified using Montage PCR plate kit (Millipore, US) according to manufacturer’s 
protocol and DNA sequencing was performed by a commercial company (1st Base Laboratories Sendirian Berhad, 
Selangor, Malaysia). Briefly, the single pass DNA sequencing encompasses cycle sequencing reactions, dye terminator 
removal and analysis on Genetic Analyzers (ABI PRISM 3730xl, Applied Biosystems, USA). The nucleotide 
sequences obtained were then used to identify the genes using the Basic Local Alignment Search Tool (BLAST) 
software system available from National Center Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov/
BLAST/) website. 
RESULTS
RNA quality and integrity 
RNA with 268/280 >1.9 were obtained from AML samples. Electrophoresis in non-denaturing agarose gel showed 
two intensive bands representing 28S and 18S rRNA (Figure 1). 
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Figure 1: Non-denaturing gel electrophoresis of RNA extracted from AML samples (lane 1 and 2). M: Lambda DNA/
EcoR I + Hind III DNA Marker. Note: Due to general differences in form and structure and migration behaviour 
between single- and double-stranded nucleic acids, 28S rRNA (~5030 nt) and 18S rRNA (~1900 nt) migrate faster 
through the non-denaturing agarose gel matrix as compared to dsDNA MW marker bands. This resulted in markers 
positions lower than expected. 
The kit recommends that RNA integrity should be checked by gel electrophoresis to observe two bright bands 
representing the 28S and 18S with ratio of 1.5-2.5:1. A 2:1 ratio for 28S:18S has long been considered the benchmark 
for intact RNA. However, with the exception of RNA prepared from cultured cells, it is rare to achieve ratio of 
2 or greater. Some 28S rRNA contain an AU-rich sequence called a “hidden break” that leads to processing into 
two smaller RNAs. Even as this piece degrades, the 18S rRNA peak remains fairly constant suggesting this is not 
associated with large-scale degradation of the RNA sample (TechNotes from ThermoFisher website (https://www.
thermofisher.com/my/en/home/references/ambion-tech-support/rna-isolation/tech-notes/assessing-rna-quality.html).
First-strand cDNA synthesis
The cDNA synthesis kit that was used provided a novel, PCR-based method for producing high-quality cDNA from 
nanogram quantities of total RNA. Unlike commonly used methods, it is able to preferentially enrich for full length 
cDNAs. A modified oligo(dT)primer (the 3’ SMART CDS Primer IIA) primes the first-strand synthesis reaction. 
When reverse transcription (RT) reaches the 5’ end of the mRNA, the enzyme’s terminal transferase activity adds a 
few additional nucleotides, primarily deoxycytidine, to the 3’ end of the cDNA. A SMART Oligonucleotide which has 
an oligo(G) sequence at its 3’ end, base-pairs with the deoxycytidine stretch, creating an extended template. RT then 
switches templates and continues replicating to the end of the oligonucleotide (Super SMART PCR cDNA synthesis 
kit user manual). 
cDNA amplification 
After first strand cDNA synthesis, amplification by LD PCR at 15 cycles and every 3 subsequent cycle, is shown in 
Figure 2. In general, cDNA synthesized from mammalian total RNA appear as a moderately strong smear from 0.5-6 
kb with some distinct bands. The optimal number of PCR cycles were determined from the gel before proceeding 
further. Optimal cycle is one cycle fewer than is needed to reach plateau. Over-cycled cDNA has less representative 
probes and poor template for cDNA subtraction. As the intensity of the cDNA smear in all tested cycles for the two 
samples was similarly high, vials amplified to cycle 15 was chosen for further experiment.
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Figure 2: Gel electrophoresis of cDNA amplified at various number of PCR cycles (15, 18, 21, 24). After 15 cycles 
of amplification, an aliquot of the product was continued for the additional number of cycles. This is to select for 
product at the exponential phase of amplification. In this experiment, PCR amplification was successfully achieved 
at 15 cycles. M: 100 bp DNA marker
Column chromatography and Rsa I digestion
Amplified ds cDNA of AML samples purified by column chromatography and subjected to Rsa I digestion is shown 
in Figure 3. Gel analysis after column chromatography was to estimate the PCR products that remained. The yield is 
typically 50%. The first and second elution was performed to check which had a higher percentage of PCR product. 
Since the first fraction had a higher yield, this fraction was used for Rsa I digestion. Rsa I digestion generates shorter, 
blunt-ended ds cDNA fragments, which are necessary for both adapter ligation and subtraction. After digestion, a 
smear should range from 0.1-2 kb as shown in the Figure 3, lanes 3.
 
 
Figure 3: Gel electrophoresis of uncut ds cDNA after LD PCR amplification and PCR purification at first column 
elution (lanes 1) and second column elution (lanes 2) followed by Rsa I digestion (lanes 3) for samples GP-AML and 
PP-AML, respectively. Before digestion, ds cDNA appears as smear from 0.5 -10kb with bright bands corresponding 
to abundant mRNA. After digestion smear range from 0.1-0.2 kb. M: 100 bp DNA marker. 
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Adapter ligation
Adapter ligation efficiency analysis on gel is shown in Figure 4. This PCR experiment to detect G3PDH gene was 
performed to verify that at least 25% of the cDNAs have adaptors on both ends. Ligation to Adapter 1 was clearly 
successful for both samples. Ligation to adapter 2R was observed for the PP AML sample though lane 4 was weak. 
The G3PDH expression varies among tissues. The band intensity for the PCR products should differ no more than 
four-fold to indicate 25% ligation. For the GP AML sample, lane 4 appeared over-amplified when PCR cycle was 
increased to 25 cycles. As most bands were present, it was confirmed that a successful ligation experiment was 
conducted. Also, previous analysis of similar ligation experiments with other samples also showed certain missing/
weak bands, however, final results of subtraction were successful (based on subtracted/unsubtracted PCR analysis 
similar to below). Thus, the missing amplified bands in the efficiency analysis here may be due to missing/poor 
quality reagents in certain PCR tubes used for this analysis. The original sample was proceeded to the subtractive 
hybridization steps.
Figure 4: Gel electrophoresis for ligation efficiency analysis. Lane 1: PCR products using Adaptor-1 ligated cDNA 
as template and the G3PDH 3’Primer and PCR Primer 1. Lane 2: PCR products using Adaptor-1 ligated cDNA as the 
template and the G3PDH 3’ and 5’ Primers. Lane 3: PCR products using Adaptor 2R-ligated cDNA as the template 
and the G3PDH 3; Primers and PCR Primer 1. Lane 4: PCR products using Adaptor 2R-ligated cDNA as the template 
and the G3PDH 3’ and 5’ Primers. PCR Primer 1 binds the adapters. Expected band sizes were observed in most lanes. 
M: 100 bp DNA marker. 
Subtractive hybridization
PCR analysis of subtraction for GP-AML and PP-AML samples are shown in Figure 5. Subtracted lanes showed 
amplification of certain bands distinct from original samples suggestive of successful subtraction.
Figure 5: Gel electrophoresis of unsubtracted (lanes 1) and hybridization subtracted (lanes 2) PCR product after 
nested PCR amplification of the GP and PP AML samples. C is PCR control subtracted cDNA. 100 bp DNA ladder 
was used as size marker.
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Cloning and colony PCR amplification
Colony PCR performed on colonies selected from agar plates are shown in Figure 6.
Figure 6: Representative gel electrophoresis of colony PCR products from individual colonies randomly selected 
from LB-ampicillin agar plates. Each lane shows PCR product from a single colony amplified using the pGEM-T 
primers. 100 bp DNA ladder was used as size marker.
A total of 93 and 91 clones were selected from subtracted libraries of GP-AML and PP-AML, respectively. These 
consisted of the majority of colonies that grew in the agar plates. Interesting genes however, may still been missed 
with this method. 
Distinct genetic profiles in differentially expressed genes from subtracted library of GP-AML and 
PP-AML samples
Single pass DNA sequencing of the PCR products provided DNA sequences of about 400 bp. These were submitted 
into the BLAST software from NBI website which identified the specific gene subtracted. List of identified genes 
from the GP- and PP-AML samples are shown in Table 1 and Table 2. Genes were grouped based on known functions 
provided from online gene ontology programs and databases (Nature Protocols; HGNC database). Gene functions 
were also obtained directly from literature. A large number of the transcripts in these libraries could not be identified 
and were listed as chromosome contigs. The tables also show the number of clones picked up that were later identified 
to have the same gene.
Table 1: Identity and characteristics of differentially expressed genes and number of clones isolated from subtracted 
library of AML samples with good prognosis (GP) 
Clone/gene (GP) Location Ref Clones 
(No)
Clones/genes (PP) Location Ref Clones 
(No)
Oxidative Phosphorylation
 COX2
 COX3
 ATP8
 ATP6
 MTND4
 ATP5B(NM_001686.3)
 COX7B(NM_001866.2)
 C16orf61/
CMC2(NM_020188.2)
 MTRNR2(16S rRNA)
Mito
Mito
Mito
Mito
Mito
12p13.3
Xq21.1
16q23.2
Mito
[8]
[8]
[8]
[8]
[8]
[8]
[8]
[9]
[10]
11
3
7
7
3
1
1
1
3
Actin Cytoskeleton
 MALAT1(NR_002819.1)
 ACTB(NM_001101.3)
 RHOA(NM_001664.2)
 ARHGDIB(NM_001175.4)
 MYL6(NM_021019.3)
 TMSB4X(NM_021109.3)
 CALM2(NM_001743.3)
12q13.1
7p22
3p21.3
12p12.3
12q13.13
Xp22.2
 2p21.3-p21.1
[14]
[8]
[8]
[8]
[8]
[8]
 [8]
6
2
1
2
1
1
 1
Iron Binding Protein
FTL(NM_000146.3) 19q13.33 [8] 1
HLA genes
 HLA-DRA(NM_019111.3)
 B2M (NM_004048.2)
6p21.3
15q21-q22.2
[9]
[9]
5
1
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Ribosome Biogenesis /Protein 
Synthesis
 NOLA2(NM_017838.3) 
 RPLP0(NM_001002.3)
 RPL9 (NM_000661.4) 
 RPL21(NM_000982.3)
 RPL27(NM_000988.3)
 RPL27A(NM_000990.4)
 RPL36A(NM_021029.4)
 RPL41(NM_021104.1)
 EEF1A1(NM_001402.5)
 EIF4A1(NM_001416.2)
 PCID1/EIF3(NM_006360.3)
 C14orf166(NM_016039.2)
5q35.3
12q24.2
4p13
13q12.2
17p21
11p15
Xq22.1
12q13
6q14.1
17p13
11p13
14q22.1
[11]
[8]
[8]
[8]
[8]
[8]
[8]
[8]
[8]
[8]
[12]
[9]
1
3
1
1
2
1
1
2
2
2
1
1
Cell Death Regulator
 CSTB(NM_000100.2)
Stress response/maintenance 
of mitochondria
 HSPA9(NM_004134.5)
Enzyme
 MPO(NM_000250.1)
 SPH(NM_004577.3)
21q22.3
5q31.1
17q23.1-q23
7p11.2
[8]
[8]
[8]
[8]
1
1
1
1
Chromatin Remodeling
 H2AFZ(NM_002106.3)
 PTMA(NM_002823.4)
 OGT(NM_181672.1)
4q23
2q37.1
Xq13
[9] [8]
[13]
5
1
1
Unknown
C6orf115/ABRAL 
(XM_941139.2)
Chromosome contig
6q24.1 [8] 1
3
Total clones 91
Table 2: Identity and characteristics of differentially expressed genes and number of clones isolated from subtracted 
library of AML samples with poor prognosis (PP)
Clone/gene (GP) Location  Ref Clones 
(No)
Clones/genes (PP) Location Ref Clones 
(No)
Aerobic glycolysis/Hypoxia
 PGK1(NM_000291.3)
 MAPK8(NM_139046.1)*
 PIM1(NM_002648.)
 HIGD1A(NM_014056.3)
 GLUL(NM_002065.4)
Xq13.3
10q11
6p21
3p22.1
1q31
[9] 
[15]
[16]
[9]
[17]
1
1
1
1
1
Hematopoiesis
 SELL(NM_000655.3)
 RHOA(NM_001664.2)
 IL3RA(NM_002183.2)
Chemokine
 CCI1(NM_002981.1)
1q23-q25
3p21.3
Xp22.3 & 
Yp13.3
17
[25]
[8]
[26]
[27]
11
1
1
4
Oxidative Phosphorylation
 COX2
 MTND4
 MTND5
Mito
Mito
Mito 
 [8]
 [8]
 [8]
1
1
1
HOX-related
 HOXA3(NM_153632.2)
 PBX3(NM_006195.5)
 ENPP4(NM_014936.4)
HOX silencing
 SF3B1(NM_012433.2)
 PHF2(NM_005392.3)
 PPIE(NM_203456.1)
7p15.2
9q33.3
6p12.3
2q33.1
9q22
1p32
[28]
[28]
[29]
[30]
[31]
[32]
1
2
1
2
1
1
Iron Binding Protein
 HBD(NM_000519.3)
 
Glucocorticoid signaling
 GLCCI1
Associated with cancer and 
neurological disease
 NBPF15(NM_173638.2)
11p15.5
7p22.2
1q36.13
[9]
[18]
[19]
1
1
1
Cell Death Regulators
 PDCD6IP(NM_013374.3)
 SON(NM_032195.1)
 DDB2(NM_000107.2)
BCAP31(NM_005745.6)
3p22.3
21q22.1-q22.2
11p12-p11
Xq28
[8]
[8]
[8]
[33]
1
1
1
1
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Ribosome Biogenesis /Protein 
Synthesis
 MRPS21(NM_031901.4)
 RPS4Y1(NM_001008.3)
 RPL19(NM_000981.3)
 BMS1P5 (NM_003611.1)
Cell Division
 KLHDC5(NM_020782.1)
 ANAPC5(NM_016237.3)
1q21
Yp11.3
17q12
10q11.22
12p11.22
12q24
 [8]
 [8]
 [8]
 [9]
[9] 
[9]
1
1
1
1
1
1
Methyltransferase
 HNMT(NM_006895.2)
 TPMT(NM_000367.2)
Calcium Transporter
 ATP2B1(NM_001682.2)
Unknown
 TTTY15(NR_001545.2)
2q22.1
6p22.3
12q21.33
Yq11.1
[9]
[8]
[9]
[9]
2
1
1
1
Fetal/Embryonic
 LCOR(NM_032440.2)
 CNOT1(NM_016284.3)
 ORMDL1(NM_016467.4)
 CENPC1(NM_001812.2)
 NRG4(NM_138573.2)
10q24
16q21
2q32
4q13.2
15q23
[20]
[21]
[22]
[23]
[24]
1
1
1
1
1
Chromosome contig 37
Total clones 93
#MAPK8 gene was isolated fused to 16S RNA
DISCUSSION
In this study, selection of samples was based on extreme ends in prognosis of patient and in vitro viability of cells. 
Other than elderly (of which neither of these samples were), gender is not a prognostic factor in AML (5). 
Gentles et al. (2010) profiled leukaemia stem cell (LSC)-samples enriched from primary AML (N=7) of and 
normal patient samples (N=7) using global gene expression (microarray). High scores from expression levels of 52 
LSC-related genes on 1047 patients were associated with worst relapse free survival (2). Other than the homeobox 
gene, no other genes were similar to those reported here. This may be due to the different groups of samples used in 
this study. Also, genes in this study could not be compared as analysis on their function was not presented. Pooling 
samples data does not allow the phenotype of individual samples to be examined, however, it is a good way to identify 
prognostic markers. Validation of the microarray identified genes further reduces the number suitable for clinical use 
(4).
This study differs from others in attempting to study the biological properties within individual acute myeloid 
leukaemia (AML) samples of clinical significance. Profiling leukemic blasts may provide clues to understanding 
response to treatment and defining characteristics of the normal counterpart. The importance of these genes as 
prognostic markers will require validation on a larger number of patient samples. 
Here, expression of early developmental stages including embryonic, fetal (LCOR, CNOT1, ORMDL1, CENPC1, 
NRG4) and HOX-related genes (HOXA3, PBX3, ENPP4, SF3B1, PHF2, PPIE) was seen in the poor prognosis (PP) 
sample. Transcriptional programs related to embryonic rather than adult stem cells were observed in leukemia stem 
cells (LSC)(34) and associated with poor survival (35).
Early relapse may be due to dormant immature cells characterized by higher frequency of CD34+(CD38-)
(35). A higher percentage of CD34+ cells was also found in the poor prognosis (PP) sample. The differential level of 
expression compared to the good prognosis sample was unclear since no clones on CD34 transcript was identified. 
Nevertheless, CD34 binds to L-selectin (36). SELL (or L-selectin) was the highest clone identified in this study. 
Selectins promote tumor metastasis by stimulating other molecules such as integrins, chemokines and a permissive 
microevironment (reviewed in Laubli and Borsig, 2010) (37). SELL, CCL1 and interleukin (IL)-3R observed in the PP 
sample may be involved in this role. Others also reported the interleukin-3 alpha chain receptor, CD123 expression to 
be specific to leukaemia stem cells and predictive of an adverse outcome in AML (38). 
Activation of IL-3R leads to downstream initiation of the glycolytic pathway to generate energy and ATP and at 
the same time suppresses oxidative phosphorylation leading to aerobic glycolysis (39). Human pluripotent cells rely 
mostly on glycolysis to meet their energy demands (40). Similar dependence of certain cancer cells on glycolysis was 
first reported by Warburg 1956 and referred to as the Warburg effect. Higher expression of PGK1 of the glycolytic 
pathway and other IL-3 mediators in aerobic glycolysis such as MAPK8/JNK1, GLUL(41) and PIM1, an oncogene 
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expressed in a wide range of tumors including of hematopoietic origin supports early origin of this leukaemic blast. 
Association of GLUL with shorter disease-free survival in cancer patients has been reported (42).
HOX-related genes such as HOXA3, PBX3, ENPP4 and HOX silencing genes such as SF3B1, PHF2, PPIE were 
genes expressed higher in the PP sample. HOX is a family of genes expressed early in life and function as master 
transcriptional regulators that control various aspects of morphogenesis and cell development. Other than a distinctive 
homeodomain, HOX are expressed in a spatio-temporal fashion. Four major clusters (HOXA-D) encode at least 39 
class I genes on four different chromosomes (28). HOX genes are found in normal adult hematopoietic stem cells 
and normal hematopoiesis in differentiation and proliferation with HOX cofactors. HOXA3, expressed in embryos 
prevents hematopoietic differentiation. Distinct patterns of HOX expression in AML are already reported (22).
SF3B1 is known to silence expression of HOX genes by forming complexes with proteins of the Polycomb 
group (PcG). SF3B1 and PcG proteins colocalize on the 5’regions of individual HOX genes (30). HOXA3 is located 
towards the 3’ region. PPIE, a nuclear cyclophilin binds to MLL and in leukemia cells has been shown to alter 
expressions of HOX genes which are targets of MLL regulation (32). Rearrangements involving MLL are of clinical 
significance in AML (5).
LCoR and CNOT1 are ligand dependent co-repressors (43) highly expressed in embryonic cells. LCoR binds 
directly to specific HDACs (histone deacetylases) which is associated with gene silencing and altered expression and 
mutations of genes that encode HDACs have been linked to tumor development (44). 
In contrast, the good prognosis sample exhibited increased activity utilizing mitochondrial oxidative 
phosphorylation for production of energy and expressing many genes associated with this pathway. This pathway is 
regulated by protein complexes known as the respiratory chain encoded by two genetic systems: the mitochondrial 
DNA (mtDNA) and nuclear DNA (nDNA). The mtDNA codes for 13 proteins including 7 NADH dehydrogenase 
(ND) subunits for complex I, a cytochrome b for complex III, 3 cytochrome c oxidase (COX) subunits for complex 
IV, and 2 ATPase (ATPase6/8) for complex V. Complex II is solely encoded by nDNA (45). The adverse contribution 
of altered cytochrome c oxidase subunits in AML has been reported (46). 
Approximately one third of the genes identified in the GP sample were involved in ribosome biogenesis or 
protein synthesis which is increased in cells undergoing proliferation. Transcription includes steps in initiation, 
elongation and termination (47).
Ribosomes are made up of half protein and half RNA. Ribosomal RNA synthesis occurs in the nucleolus which 
is then assembled with 82 ribosomal proteins to become ribosomes (47) were well represented in the GP library.
Chromatin remodeling and actin cytoskeleton genes are elements that serve in maintenance of cellular shape as 
well as cellular migration, cell division and cell remodeling. TMSB4X encodes an actin sequestering protein involved 
in angiogenesis, cell proliferation, migration, and differentiation (48). Studies show cell migration indicates poor 
prognosis (14).
CONCLUSION
Thus, subtractive hybridization isolated distinct gene patterns from the good and poor prognosis AML patient samples. 
Gene functions as identified in Table 1 and Table 2 were studies of normal stem cells and thus patterns here were 
reflective of normal hematopoietic hierarchy. The poor prognosis sample contained many stem cell associated genes 
suggestive of its leukemic stem cell origin. Many of the genes were also cancer related and are potential prognostic 
markers and targets for therapy.
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